STE STERIS plc

Price (delayed)

$231.52

Market cap

$22.9B

P/E Ratio

60.45

Dividend/share

$2.08

EPS

$3.83

Enterprise value

$26.07B

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been ...

Highlights
STE's P/E is 26% below its last 4 quarters average of 80.7 and 9% below its 5-year quarterly average of 65.5
The revenue has grown by 13% YoY and by 3.1% from the previous quarter
STERIS's debt has increased by 4.2% YoY but it has decreased by 3.6% from the previous quarter
The company's net income fell by 33% QoQ
The company's EPS fell by 33% QoQ

Key stats

What are the main financial stats of STE
Market
Shares outstanding
98.9M
Market cap
$22.9B
Enterprise value
$26.07B
Valuations
Price to book (P/B)
3.63
Price to sales (P/S)
4.45
EV/EBIT
38.79
EV/EBITDA
21.07
EV/Sales
5.07
Earnings
Revenue
$5.14B
EBIT
$672.12M
EBITDA
$1.24B
Free cash flow
$620.33M
Per share
EPS
$3.83
Free cash flow per share
$6.28
Book value per share
$63.78
Revenue per share
$52
TBVPS
$49.32
Balance sheet
Total assets
$11.06B
Total liabilities
$4.75B
Debt
$3.38B
Equity
$6.3B
Working capital
$1.94B
Liquidity
Debt to equity
0.54
Current ratio
3.08
Quick ratio
1.31
Net debt/EBITDA
2.57
Margins
EBITDA margin
24.1%
Gross margin
43.2%
Net margin
7.4%
Operating margin
16.3%
Efficiency
Return on assets
3.4%
Return on equity
6%
Return on invested capital
10.1%
Return on capital employed
6.6%
Return on sales
13.1%
Dividend
Dividend yield
0.9%
DPS
$2.08
Payout ratio
54.3%

STE stock price

How has the STERIS stock price performed over time
Intraday
1.2%
1 week
1.7%
1 month
6.14%
1 year
-0.25%
YTD
5.31%
QTD
5.46%

Financial performance

How have STERIS's revenue and profit performed over time
Revenue
$5.14B
Gross profit
$2.22B
Operating income
$836.12M
Net income
$378.24M
Gross margin
43.2%
Net margin
7.4%
STE's operating margin is down by 39% since the previous quarter and by 6% year-on-year
STE's operating income is down by 38% from the previous quarter but it is up by 6% YoY
STERIS's net margin has decreased by 35% from the previous quarter
The company's net income fell by 33% QoQ

Growth

What is STERIS's growth rate over time

Valuation

What is STERIS stock price valuation
P/E
60.45
P/B
3.63
P/S
4.45
EV/EBIT
38.79
EV/EBITDA
21.07
EV/Sales
5.07
The company's EPS fell by 33% QoQ
STE's P/E is 26% below its last 4 quarters average of 80.7 and 9% below its 5-year quarterly average of 65.5
The company's equity rose by 3.7% YoY
STE's P/B is 2.6% above its 5-year quarterly average of 3.5 and 2.6% above its last 4 quarters average of 3.5
The revenue has grown by 13% YoY and by 3.1% from the previous quarter
The P/S is 6% below the 5-year quarterly average of 4.7 and 2.2% below the last 4 quarters average of 4.5

Efficiency

How efficient is STERIS business performance
STERIS's ROIC has soared by 84% YoY but it has decreased by 25% from the previous quarter
The company's return on sales has surged by 75% YoY but it fell by 27% QoQ
The ROE has decreased by 34% from the previous quarter
STERIS's ROA has decreased by 33% from the previous quarter

Dividends

What is STE's dividend history
DPS
$2.08
Dividend yield
0.9%
Payout ratio
54.3%
Recent dividends

Financial health

How did STERIS financials performed over time
The total assets is 133% more than the total liabilities
STERIS's current ratio has increased by 32% YoY and by 27% QoQ
STE's total liabilities is down by 5% since the previous quarter
STERIS's debt is 46% less than its equity
STERIS's debt has increased by 4.2% YoY but it has decreased by 3.6% from the previous quarter
The company's equity rose by 3.7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.